Albert A. Luderer, Ph.D., has 40 years of successful leadership in therapeutic development, medical diagnostics and laboratory medicine and their commercialization. Dr. Luderer previously served as CEO of Integrated Diagnostics that discovered and commercialized the first noninvasive cancer rule out test for early stage non-small cell lung carcinoma. Integrated Diagnostics was acquired by Biodesix July 2018. He previously served as CEO of BioTrove acquired by Life Technologies December 2009. Prior positions included: CEO of therapeutics company Light Sciences; President of bioMérieux; Vice President Technology and Business Development, Dianon Systems (now Lab Corp); Vice President Technology Development and Support, Boehringer Mannheim (Now Roche) and; Head of Biomedical Research, Ciba Corning (Now Siemens). Dr. Luderer holds a Ph.D. from Rutgers University where he was an NSF pre doctoral fellow and performed postgraduate work in immunology at Jefferson Medical College.